Project Grant HT94252411046
Award Date
11/1/24
Completion Date
10/31/28
Dollars Obligated
$6.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Diego, CA 92121, USA
Similar Awards
This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The Defense Health Agency awarded a $749,905 Project Grant to The Roskamp Institute Inc. under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 2023 through September 2026 to investigate microglial NOX2/NLRP3 inflammasome activation and its role in driving tau pathology and cognitive impairments in chronic traumatic brain injury. Specifically, the Roskamp Institute will conduct basic, applied, and advanced biomedical...
The Washington University Office of Sponsored Research Services Division was awarded a $1,377,119 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct the study "AD GENETIC RISK AS A PROGNOSTIC FACTOR FOR COGNITIVE OUTCOMES AFTER TBI" over a 4-year period from September 2024 to September 2028. This federal grant supports innovative biomedical research aimed at improving health outcomes for military service...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,314,065.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research on the "Dose-Response Relationship of Acute TBI Blood Biomarkers with Pathoanatomic Neuroimaging Findings". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing biomedical research on...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $2,449,123 project grant to the Northern California Institute for Research and Education, Inc. (NCIRE) to conduct the "TBI Rehabilitation and Activation in Veterans (TRAIN-VETS)" research project. The grant, awarded on September 1, 2024, will fund a 4-year study to develop and evaluate innovative rehabilitation approaches for improving outcomes for veterans with traumatic...
The U.S. Defense Health Agency awarded a $817,200 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Roskamp Institute, Inc. in Sarasota, Florida. The grant, awarded on September 1, 2024, will support a 3-year research project titled "Targeting APOE Bioenergetics for Reducing the Risk of Neurodegeneration After Chronic Traumatic Brain Injury." The research aims to investigate mitochondrial bioenergetics, tau protein pathology,...
The federal Project Grant award of $837,500.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by The Feinstein Institutes for Medical Research on "OXYGEN CONSERVING REFLEX: A NOVEL MULTIMECHANISTIC THERAPEUTIC INTERVENTION FOR TBI." The research will investigate an innovative approach to address traumatic brain injury (TBI) by examining a novel oxygen conserving reflex. The award will support this...
The Defense Health Agency awarded a $1,131,357 Project Grant titled "MicroRNA Biomarkers of Cumulative Blast-Mild Traumatic Brain Injury (Micro BCB)" under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research conducted by the Seattle Institute for Biomedical and Clinical Research, a non-profit institute, to investigate the use of microRNA biomarkers for detecting and monitoring the impact of mild traumatic brain injury related to blast...
The Defense Health Agency awarded a $1,633,104 Project Grant to The Roskamp Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420) to develop highly selective DYRK1A inhibitors as a novel therapeutic approach for traumatic brain injury. The grant, which runs from June 15, 2024 to June 14, 2028, supports the organization's research to understand the causes of and find cures for neuropsychiatric and neurodegenerative disorders. The Roskamp Institute, a non-profit...